Back to DE D. E. Shaw & Co., Inc.

CCCCCCCC
23 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in C4 THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 1.7M shares of CCCC (C4 THERAPEUTICS INC), worth $8.1M as of 2026-Q2. The position was increased (+64.2% shares). CCCC represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$8.1M

Current Shares

1.7M

Total Value Change

+$7.7M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+64.2%
$8.1M0.0%$4.67
40
2026-Q1
Increased
1.1M
+1905.2%
$2.8M0.0%$2.95
42
2025-Q4
Increased
52,879
+345.8%
$100,9990.0%$1.96
35
2025-Q3
Decreased
11,863
-86.7%
$26,3360.0%$2.23
0
2025-Q2
Increased
89,475
+12.9%
$127,9490.0%$1.40
25
2025-Q1
Increased
79,275
+3.7%
$126,8400.0%$1.75
23
2024-Q4
Decreased
76,479
-35.7%
$275,3240.0%$3.64
0
2024-Q3
Decreased
118,892
-66.6%
$677,6840.0%$5.89
0
2024-Q2
Decreased
356,212
-28.3%
$1.6M0.0%$4.62
0
2024-Q1
Increased
496,543
+103.8%
$4.1M0.0%$8.17
43
2023-Q4
Decreased
243,638
-43.9%
$1.4M0.0%$5.65
0
2023-Q3
Decreased
434,110
-16.4%
$807,4440.0%$1.86
0
2023-Q2
Increased
519,179
+167.4%
$1.4M0.0%$2.75
41
2023-Q1
Increased
194,161
+125.9%
$609,6660.0%$3.10
39
2022-Q4
Decreased
85,961
-33.9%
$507,1700.0%$5.90
0
2022-Q3
Increased
130,082
+65.1%
$1.1M0.0%$8.54
37
2022-Q2
New
78,788
-
$594,0000.0%$7.34
34
2022-Q1
Exited
0
-100.0%
$00.0%$24.07
0
2021-Q4
Increased
25,735
+160.4%
$829,0000.0%$32.88
40
2021-Q3
Decreased
9,883
-40.2%
$442,0000.0%$47.97
0
2021-Q2
Increased
16,532
+204.5%
$626,0000.0%$37.10
39
2021-Q1
Decreased
5,430
-56.8%
$201,0000.0%$32.90
0
2020-Q4
New
12,574
-
$417,0000.0%$35.94
33

Other major holders of CCCC: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used